Novartis

  • A Phase III Trial for Patients with Advanced or Metastatic Non Small Cell Lung Cancer (CASA404A2302) — Lung Cancer Trials
  • A Phase III Trial of Post-Menopausal Women with Locally Advanced or Metastatic Breast Cancer (CRAD001Y2301) — Breast Cancer Trials